Article
A novel mutation of the human 7-dehydrocholesterol reductase gene reduces enzyme activity in patients with holoprosencephaly.
Biochemical and biophysical research communications - 27 Feb 2004
Shim Yhong-Hee, Bae Soo-Han, Kim Jai-Hyun, Kim Kyu-Rae, Kim Chong Jai, Paik Young-Ki
Abstract excerpt
Defects in cholesterol biosynthesis genes are recognized as a leading cause for holoprosencephaly (HPE). Previous reports suggest that mutations of human 7-dehydrocholesterol reductase (Dhcr7), which catalyzes the final step of cholesterol biosynthesis, may cause HPE [Clin. Genet. 53 (1998) 155]. To determine whether Dhcr7 mutations are involved in HPE pathogenesis, we analyzed the sequence of exon 9, which...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
